See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
Image: Bigstock
Long/Short ETF (BTAL) Hits New 52-Week High
For investors seeking momentum, AGFiQ US Market Neutral Anti-Beta Fund (BTAL - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 21.2% from its 52-week low price of $12.73/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BTAL in Focus
The underlying Dow Jones U.S. Thematic Market Neutral Anti-Beta Index is a long/short market neutral index that is dollar-neutral. The fund charges 76 bps in fees (see all Long-Short ETFs here).
Why the Move?
Since markets remained volatile lately and there was a bloodbath in the global market at the start of August owing mainly to renewed U.S.-China trade tensions and China’s yuan devaluation, this defensive ETF gained strength.
More Gains Ahead?
The fund has a positive weighted alpha of 19.50. So, there is definitely still some promise for those who want to ride on this surging ETF a little longer, especially if uncertainty remains in the market.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>